Deals and data in the offing for Oncimmune
Oncimmune is not the only company looking to use the immune system to diagnose cancer. But its growth plans are intense, and it intends to prove the economic benefits of…
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.